Abbott Laboratories (ABT) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0028241000

Pharmaceuticals, Diagnostics, Nutritionals, Medical Devices

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a wide range of healthcare products. The company operates through four main segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

In the pharmaceutical segment, Abbott offers a broad portfolio of generic medicines to treat various health conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome, hormone replacement therapy, dyslipidemia, hypertension, and more. These medicines help patients manage their health and improve their quality of life.

In the diagnostic segment, Abbott provides a wide range of diagnostic systems and tests for laboratories and healthcare professionals. These include laboratory and transfusion medicine systems, molecular diagnostics, point-of-care systems, and rapid diagnostics lateral flow testing products. These solutions help healthcare professionals diagnose and monitor diseases, including infectious diseases like COVID-19, influenza, and HIV.

Apart from pharmaceuticals and diagnostics, Abbott also offers a range of nutritional products for pediatric and adult nutrition, including formulas and supplements. These products are designed to support healthy growth and development in infants, children, and adults.

In the medical devices segment, Abbott provides a range of devices and solutions for cardiovascular diseases, diabetes care, and neuromodulation. These include rhythm management, electrophysiology, heart failure, vascular, and structural heart devices, as well as glucose and blood glucose monitoring systems, and devices for the management of chronic pain and movement disorders.

Founded in 1888, Abbott Laboratories is headquartered in North Chicago, Illinois, and has a strong presence in over 160 countries worldwide. With a rich history of innovation and a commitment to improving healthcare, Abbott continues to develop new products and solutions to address the evolving needs of patients and healthcare professionals.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Abbott Laboratories (ABT) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Abbott Laboratories (ABT) - Stock Price & Dividends

ABT Stock Overview

Market Cap in USD 181,391m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1978-01-13

ABT Stock Ratings

Growth 5y 25.0
Fundamental 49.7
Dividend 8.14
Rel. Performance vs Sector -1.13
Analysts 4.25/5
Fair Price Momentum 93.14 USD
Fair Price DCF 77.56 USD

ABT Dividends

Yield 12m 2.01%
Yield on Cost 5y 2.72%
Dividends CAGR 5y 9.77%
Payout Consistency 98.4%

ABT Growth Ratios

Growth 12m -0.17%
Growth Correlation 12m 18%
Growth Correlation 3m -64%
CAGR 5y 6.31%
CAGR/Mean DD 5y 0.48
Sharpe Ratio 12m -0.30
Alpha vs SP500 12m -23.15
Beta vs SP500 5y weekly 0.80
ValueRay RSI 61.02
Volatility GJR Garch 1y 18.51%
Price / SMA 50 0.42%
Price / SMA 200 0.18%
Current Volume 5492k
Average Volume 20d 5792k

External Links for ABT Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of ABT stocks?
As of June 22, 2024, the stock is trading at USD 105.72 with a total of 5,491,992 shares traded.
Over the past week, the price has changed by +1.97%, over one month by +2.68%, over three months by -4.72% and over the past year by +1.52%.
What are the forecast for ABT stock price target?
According to ValueRays Forecast Model, ABT Abbott Laboratories will be worth about 102.9 in June 2025. The stock is currently trading at 105.72. This means that the stock has a potential downside of -2.71%.
Issuer Forecast Upside
Wallstreet Target Price 125.7 18.9
Analysts Target Price 110.7 4.66
ValueRay Target Price 102.9 -2.71

Abbott Laboratories: A Comprehensive Overview

The History of Abbott Laboratories

Founded by Dr. Wallace C. Abbott in 1888, Abbott Laboratories started as a small pharmaceutical operation in Chicago. Its inception was marked by the innovative approach of Dr. Abbott, who began by formulating known drugs into tiny, easy-to-use pills. This was a significant departure from traditional practices, setting the stage for a legacy of innovation. Over the decades, Abbott expanded its reach, not just in pharmaceuticals, but also into diagnostics, medical devices, and nutrition, thereby solidifying its place in the healthcare industry.

Core and Side Businesses

Abbott Laboratories operates through four main business segments:

  • Diagnostics: Offers a wide range of diagnostic systems and tests for detection of diseases.
  • Medical Devices: This comprises cardiovascular devices and diabetes care products that help people manage their health effectively.
  • Nutrition: Nutrition segment produces infant formulas, nutritional products for children, and dietetic foods.
  • Branded Generic Pharmaceuticals: Provides a broad line of branded, generic pharmaceuticals, primarily in emerging markets.

Aside from these core segments, Abbott has also ventured into other areas through strategic acquisitions, technology advancements, and research initiatives, which further diversify its operations and strengthen its market position.

Current Market Status

Today, Abbott Laboratories is recognized as a global leader in healthcare, with its products reaching millions across the world. The company's commitment to innovation has powered its growth, with significant investments in research and development. Financially, Abbott has demonstrated robust performance, with steady revenue growth and a strong stock market presence, showcasing its resilience and adaptability in the face of changing market dynamics. As of 2023, Abbott continues to expand its global reach and impact, staying true to its mission of providing cutting-edge, accessible healthcare solutions.